16.39% to Target, Morgan Stanley Reconfirms “Equalwt/Cautious” Rating for

Shares of KAZ Minerals PLC (LON:KAZ) have earned a consensus rating of “Hold” from the eighteen research firms that are now covering the stock, Market Beat Ratings reports.

Shares of AdEPT Telecom plc (LON:ADT) opened at 260.00 on Monday. Severn Trent Plc has a 52 week low of GBX 1,814.00 and a 52 week high of GBX 2,227.00. The primary factors that have impacted our rating are mixed, a few indicating strength, a few showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks.

Several other analysts also recently weighed in on WOS. Stifel Nicolaus restated a buy rating and issued a GBX 75 ($1.14) price target on shares of Centamin PLC in a research note on Wednesday, June 17th. The average 1-year price objective among brokerages that have updated their coverage on the stock in the a year ago is GBX 18.24 ($0.28). The company has a market cap of 3.08B GBP and a P/E ratio of 23.18. Jefferies global have set a target price of 602 GBX on its stock. Nine investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the stock.

KAZ Minerals PLC, formerly Kazakhmys PLC, is a United Kingdom-based copper company.

Liberum Capital reaffirmed a “buy” rating and issued a GBX 469 ($7.13) price objective on shares of M J Gleeson Group PLC in a research report on Wednesday, August 12th. The 50-day moving average is $4.78 and the 200 day moving average is recorded at $5.08. The Company is focused on open-pit mining in Kazakhstan. The Company’s products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSE VUXEN/ADUVANZ (lisdexamfetamine dimesylate), ADDERALL XR (mixed salts of a single-entity amphetamine), INTUNIV (extended release guanfacine), EQUASYM (methylphenidate hydrochloride) altered release (XL), BUCCOLAM, LIALDA (mesalamine)/ MEZAVANT(mesalazine), PENTASA (mesalamine), RESOLOR (prucalopride), REPLAGAL (agalsidase alfa), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), CINRYZE C1 esterase inhibitor (individual), FOSRENOL (lanthanum carbonate), XAGRID/ AGRYLIN (anagrelide hydrochloride) and PLENADREN (modified release hydrocortisone). Its mining operations produce copper with byproducts of gold, molybdenum and silver. The Business operates through two segments: Severn Trent Water and Severn Trent Services. Moreover, the Firm, through its subsidiary company, Antofagasta Investment Company Limited, owns 100% ownership in the Twin Metals Minnesota Project (TMM), a copper-nickel-platinum-palladium-gold-silver project in north eastern Minnesota, the United States.